Andrew Worne of Cavendish Securities sits down with Dr Sandy Nairn and Alan Bartlett of Global Opportunities Trust PLC (LON:GOT) to unpack how their agile, high-conviction strategy is helping investors navigate uncertainty...
Dr Brian Moretta explains how disciplined deal-making, strong cash generation, and operational progress across the UK and Europe are reinforcing Chesnara’s position..
Executive Director Dr Dan Gooding outlines how this validation not only highlights the urgent unmet need in IPF but also sharpens Nuformix’s commercial edge with 10 years of market exclusivity and accelerated development support..
CEO Mark Bartlett shares a striking roadmap for the year ahead, revealing how the global leader in kettle safety controls is positioning itself for a major rebound...
CEO Sam Bazini shares how the company smashed through £100 million in revenue, integrated a transformative acquisition, expanded into major retailers like Walmart and Superdrug, and why 2025 could see even bigger leaps...
Analyst Mark Thomas of Hardman & Co breaks down how the Group is building long-term shareholder value by expanding specialist lending, attracting new banking clients, and scaling its wealth management business...
